• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NeoGenomics, Inc. - Common Stock (NQ:NEO)

    5.200 +0.360 (+7.44%)
    Streaming Delayed Price Updated: 1:58 PM EDT, Aug 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,429,178
    Open 4.810
    Bid (Size) 5.190 (12)
    Ask (Size) 5.200 (3)
    Prev. Close 4.840
    Today's Range 4.720 - 5.239
    52wk Range 4.780 - 19.11
    Shares Outstanding 122,816,314
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
    From Pomerantz LLP
    Via GlobeNewswire
    A Glimpse Into The Expert Outlook On NeoGenomics Through 3 Analysts
     
    Via Benzinga

    Performance

    YTD
    -68.5%
    -68.5%
    1 Month
    -29.8%
    -29.8%
    3 Month
    -28.4%
    -28.4%
    6 Month
    -64.9%
    -64.9%
    1 Year
    -70.7%
    -70.7%

    More News

    Read More
    NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy
    From NeoGenomics, Inc.
    Via Business Wire
    Earnings Scheduled For July 29, 2025
    Via Benzinga
    Why NeoGenomics (NEO) Shares Are Falling Today
    Via StockStory
    Topics Lawsuit
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    NeoGenomics (NASDAQ:NEO) Misses Q2 Sales Targets, Stock Drops 15.8%
    Via StockStory
    NeoGenomics Reports Second Quarter 2025 Results
    From NeoGenomics, Inc.
    Via Business Wire
    NeoGenomics (NEO) Reports Q2: Everything You Need To Know Ahead Of Earnings
    Via StockStory
    Topics Artificial Intelligence
    3 of Wall Street’s Favorite Stocks We’re Skeptical Of
    Via StockStory
    Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know
    Via StockStory
    Topics Lawsuit World Trade
    3 Stocks Under $10 We’re Skeptical Of
    Via StockStory
    Q1 Earnings Highlights: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Testing & Diagnostics Services Stocks
    Via StockStory
    NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know
    Via StockStory
    Topics ETFs Stocks World Trade
    3 Russell 2000 Stocks with Questionable Fundamentals
    Via StockStory
    Topics Artificial Intelligence
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO
    From Pomerantz LLP
    Via GlobeNewswire
    NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
    From NeoGenomics, Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO
    Via ACCESS Newswire
    NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
    From NeoGenomics, Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO
    Via ACCESS Newswire
    Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
    Via Benzinga
    Topics Artificial Intelligence
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEO
    Via ACCESS Newswire

    Frequently Asked Questions

    Is NeoGenomics, Inc. - Common Stock publicly traded?
    Yes, NeoGenomics, Inc. - Common Stock is publicly traded.
    What exchange does NeoGenomics, Inc. - Common Stock trade on?
    NeoGenomics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NeoGenomics, Inc. - Common Stock?
    The ticker symbol for NeoGenomics, Inc. - Common Stock is NEO on the Nasdaq Stock Market
    What is the current price of NeoGenomics, Inc. - Common Stock?
    The current price of NeoGenomics, Inc. - Common Stock is 5.200
    When was NeoGenomics, Inc. - Common Stock last traded?
    The last trade of NeoGenomics, Inc. - Common Stock was at 08/01/25 01:58 PM ET
    What is the market capitalization of NeoGenomics, Inc. - Common Stock?
    The market capitalization of NeoGenomics, Inc. - Common Stock is 638.64M
    How many shares of NeoGenomics, Inc. - Common Stock are outstanding?
    NeoGenomics, Inc. - Common Stock has 639M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.